123 related articles for article (PubMed ID: 7867082)
1. Patterns of interferon-gamma mRNA expression in toxic shock syndrome toxin-1 expanded V beta 11+ T lymphocytes.
Zhao YX; Abdelnour A; Ljungdahl A; Olsson T; Tarkowski A
Cell Immunol; 1995 Mar; 161(1):28-33. PubMed ID: 7867082
[TBL] [Abstract][Full Text] [Related]
2. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
3. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci.
Abdelnour A; Bremell T; Holmdahl R; Tarkowski A
Eur J Immunol; 1994 May; 24(5):1161-6. PubMed ID: 8181526
[TBL] [Abstract][Full Text] [Related]
4. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
[TBL] [Abstract][Full Text] [Related]
5. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the early response to TSST-1 reveals Vbeta-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1.
Waclavicek M; Stich N; Rappan I; Bergmeister H; Eibl MM
J Leukoc Biol; 2009 Jan; 85(1):44-54. PubMed ID: 18923105
[TBL] [Abstract][Full Text] [Related]
7. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
Kum WW; Hung RW; Cameron SB; Chow AW
J Infect Dis; 2002 Feb; 185(4):555-60. PubMed ID: 11865410
[TBL] [Abstract][Full Text] [Related]
8. Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1.
Kalyan S; Chow AW
J Infect Dis; 2004 May; 189(10):1892-6. PubMed ID: 15122526
[TBL] [Abstract][Full Text] [Related]
9. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+V beta 8+ and CD8+V beta 8+ T cells.
Sabapathy TK; Hwang LA; Hui KM
Cell Immunol; 1994 Oct; 158(1):83-95. PubMed ID: 7916268
[TBL] [Abstract][Full Text] [Related]
12. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
[TBL] [Abstract][Full Text] [Related]
14. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
15. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
Norton SD; Schlievert PM; Novick RP; Jenkins MK
J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
[TBL] [Abstract][Full Text] [Related]
16. Synoviocyte proliferation in joints of SCID mice induced by toxic shock syndrome toxin-1 stimulated T cells from patient with rheumatoid arthritis.
Suzuki T; Nishimaki T; Kogure A; Okubo M; Akatsuka H; Kokubun M; Kasukawa R; Natsume T; Suzuki T
J Rheumatol; 1997 Jun; 24(6):1115-21. PubMed ID: 9195519
[TBL] [Abstract][Full Text] [Related]
17. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
18. Toxic shock syndrome toxin-1 accelerated collagen-induced arthritis in mice.
Kageyama Y; Koide Y; Nagata T; Uchijima M; Yoshida A; Arai T; Miura T; Miyamoto C; Nagano A
J Autoimmun; 2001 Mar; 16(2):125-31. PubMed ID: 11247638
[TBL] [Abstract][Full Text] [Related]
19. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
20. Induction of selective anergy by toxic shock syndrome toxin-1 in CD8+ T cells.
Zhao YX; Holmdahl R; Tarkowski A
Immunology; 1997 Oct; 92(2):188-93. PubMed ID: 9415025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
